BioCentury | Oct 27, 1997
Clinical News

Thin film ozone technology: Phase I and II Update

Medizone International Inc. (MZEI.U), Salt Lake City, Utah Product: Thin film ozone technology Indication: Treat HIV infection Status: MZEI.U plans to start Phase I/II testing in Italy in the first quarter of 1998, to determine...
BioCentury | Jul 3, 1995
Company News

Medizone deal

...MZEI (New York) and Solwin Investments Ltd. formed Medizone New Zealand Ltd., a 50/50 joint venture...
...for regulatory approval and for licensing MZEI's technology in New Zealand and other areas. MZEI Medizone...
...an ozone-based treatment for diseases caused by lipid-enveloped viruses, including AIDS, hepatitis B and herpes. Medizone...
BioCentury | Jun 7, 1993
Clinical News

Medizone data

...Medizone International Inc. (MZEI) Medizone International Inc. (MZEI) has completed the first two phases of a monkey trial...
Items per page:
1 - 3 of 3
BioCentury | Oct 27, 1997
Clinical News

Thin film ozone technology: Phase I and II Update

Medizone International Inc. (MZEI.U), Salt Lake City, Utah Product: Thin film ozone technology Indication: Treat HIV infection Status: MZEI.U plans to start Phase I/II testing in Italy in the first quarter of 1998, to determine...
BioCentury | Jul 3, 1995
Company News

Medizone deal

...MZEI (New York) and Solwin Investments Ltd. formed Medizone New Zealand Ltd., a 50/50 joint venture...
...for regulatory approval and for licensing MZEI's technology in New Zealand and other areas. MZEI Medizone...
...an ozone-based treatment for diseases caused by lipid-enveloped viruses, including AIDS, hepatitis B and herpes. Medizone...
BioCentury | Jun 7, 1993
Clinical News

Medizone data

...Medizone International Inc. (MZEI) Medizone International Inc. (MZEI) has completed the first two phases of a monkey trial...
Items per page:
1 - 3 of 3